319 related articles for article (PubMed ID: 28540976)
1. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
Perry LA; Berge E; Bowditch J; Forfang E; Rønning OM; Hankey GJ; Villanueva E; Al-Shahi Salman R
Cochrane Database Syst Rev; 2017 May; 5(5):CD012144. PubMed ID: 28540976
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic treatment after stroke due to intracerebral haemorrhage.
Cochrane A; Chen C; Stephen J; Rønning OM; Anderson CS; Hankey GJ; Al-Shahi Salman R
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012144. PubMed ID: 36700520
[TBL] [Abstract][Full Text] [Related]
3. Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage.
Eilertsen H; Menon CS; Law ZK; Chen C; Bath PM; Steiner T; Desborough MJ; Sandset EC; Sprigg N; Al-Shahi Salman R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD005951. PubMed ID: 37870112
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic therapies for acute spontaneous intracerebral haemorrhage.
Al-Shahi Salman R; Law ZK; Bath PM; Steiner T; Sprigg N
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005951. PubMed ID: 29664991
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulants for acute ischaemic stroke.
Wang X; Ouyang M; Yang J; Song L; Yang M; Anderson CS
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD000024. PubMed ID: 34676532
[TBL] [Abstract][Full Text] [Related]
7. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Okpo E; Forster R
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
[TBL] [Abstract][Full Text] [Related]
9. Marine-derived n-3 fatty acids therapy for stroke.
Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
[TBL] [Abstract][Full Text] [Related]
10. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
Naqvi IA; Kamal AK; Rehman H
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Leong TS
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD000119. PubMed ID: 28374884
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Counsell C; Tseng MC
Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
[TBL] [Abstract][Full Text] [Related]
13. Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis.
Wang T; Luo J; Wang X; Yang K; Jadhav V; Gao P; Ma Y; Zhao N; Jiao L
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013267. PubMed ID: 32789891
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
17. Remote ischaemic conditioning for preventing and treating ischaemic stroke.
Zhao W; Zhang J; Sadowsky MG; Meng R; Ding Y; Ji X
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012503. PubMed ID: 29974450
[TBL] [Abstract][Full Text] [Related]
18. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
Shantsila E; Lip GY
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
[TBL] [Abstract][Full Text] [Related]
20. Thrombolytic therapy for pulmonary embolism.
Zuo Z; Yue J; Dong BR; Wu T; Liu GJ; Hao Q
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004437. PubMed ID: 33857326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
